Standout Papers

Ozanimod as Induction and Maintenance Therapy for Ulcerative Colitis 2021 2026 2022 2024313
  1. Ozanimod as Induction and Maintenance Therapy for Ulcerative Colitis (2021)
    William J. Sandborn, Brian G. Feagan et al. New England Journal of Medicine

Immediate Impact

1 from Science/Nature 33 standout
Sub-graph 1 of 13

Citing Papers

PD-1 signaling limits expression of phospholipid phosphatase 1 and promotes intratumoral CD8+ T cell ferroptosis
2024 Standout
A systematic framework for understanding the microbiome in human health and disease: from basic principles to clinical translation
2024 Standout
2 intermediate papers

Works of AnnKatrin Petersen being referenced

Ozanimod as Induction and Maintenance Therapy for Ulcerative Colitis
2021 Standout
Long-Term Efficacy and Safety of Ozanimod in Moderately to Severely Active Ulcerative Colitis: Results From the Open-Label Extension of the Randomized, Phase 2 TOUCHSTONE Study
2021

Author Peers

Author Last Decade Papers Cites
AnnKatrin Petersen 310 191 43 103 12 454
Maria Weidinger 266 159 17 36 14 394
Willem-Jan Wollants 282 163 8 81 9 392
A Dasgupta 191 166 78 68 16 474
F. Pallone 326 265 21 55 15 490
Julien Verdier 194 119 23 138 21 496
P. Rutgeerts 287 223 18 41 10 452
Pilar Martínez-Montiel 280 238 49 27 22 431
Esther Vogels 173 82 28 137 17 503
Mary Beth Bowen-Yacyshyn 195 96 11 175 8 493
Maria E. Joosse 179 86 17 176 16 445

All Works

Loading papers...

Rankless by CCL
2026